Samoa vs Western Pacific (WHO region): New cases tested for RR-/MDR-TB
Samoa
100.0%
in 2024
Western Pacific (WHO region)
89.0%
in 2024
Samoa rank
1st
Western Pacific (WHO region) rank
2nd
New cases tested for RR-/MDR-TB over time
- Samoa
- Western Pacific (WHO region)
How they compare
Samoa currently reports 100.0% against 89.0% in Western Pacific (WHO region), a difference of 11.0%.
That makes Samoa's figure about 1.1 times Western Pacific (WHO region)'s.
The two have swapped places 5 times across 12 shared years of data; in 2010 it was Western Pacific (WHO region) ahead.
Samoa ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
Across the 2 decades both report, Samoa averaged higher in 1 and Western Pacific (WHO region) in 1.
Head to head by decade
| Decade | Samoa | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 73.0% | 23.8% | 49.2% | Samoa |
| 2020s | 75.0% | 82.2% | 7.2% | Western Pacific (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Samoa or Western Pacific (WHO region)?
- Samoa, at 100.0% against 89.0% in Western Pacific (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Samoa and Western Pacific (WHO region)?
- 11.0%, with Samoa ahead.
- How many years of comparable data are there for Samoa and Western Pacific (WHO region)?
- 12 years are reported by both, from 2010 to 2024.
- How do Samoa and Western Pacific (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Samoa ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.